<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-38205" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Enterohemorrhagic Escherichia coli</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Fatima</surname>
            <given-names>Rawish</given-names>
          </name>
          <aff>University of Toledo medical center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Aziz</surname>
            <given-names>Muhammad</given-names>
          </name>
          <aff>University of Toledo Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rawish Fatima declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Muhammad Aziz declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-38205.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Enterohemorrhagic Escherichia coli (EHEC) is a bacterial infection resulting in bloody dysentery and an increased risk of hemolytic uremic syndrome (HUS). EHEC serotype O157:H7 is responsible for global outbreaks of bloody diarrhea and HUS. This activity reviews the presentation, evaluation, and management of enterohemorrhagic Escherichia coli and highlights the role of the interprofessional team in caring for patients affected by this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the clinical manifestations of enterohemorrhagic Escherichia coli (EHEC).</p></list-item><list-item><p>Describe the evaluation of a patient suspected of having enterohemorrhagic Escherichia coli (EHEC).</p></list-item><list-item><p>Explain the management of enterohemorrhagic Escherichia coli (EHEC).</p></list-item><list-item><p>The management of enterohemorrhagic Escherichia coli (EHEC) is interprofessional. In general, the primary care provider and nurse practitioner should educate the patient on the prevention of foodborne diseases. This can be achieved most effectively through the application of food safety assurance programs.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=38205&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=38205">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-38205.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Escherichia coli </italic>is a gram-negative, rod-shaped bacteria belonging to the genus <italic toggle="yes">Escherichia</italic> that commonly resides in the human colon. Shigatoxigenic along with verotoxigenic <italic toggle="yes">E. coli</italic> (STEC), (VTEC) are strains of <italic toggle="yes">E. coli</italic> that are known to produce Shiga toxin and Shiga-like toxin (verotoxin) respectively. The strains that cause ailments in humans are commonly known as enterohemorrhagic <italic toggle="yes">E. coli</italic> (EHEC). The terms mentioned above are often used interchangeably. EHEC serotype O157:H7 is a human pathogen found to be responsible for bloody diarrhea outbreaks and hemolytic uremic syndrome (HUS) worldwide.&#x000a0;<xref ref-type="bibr" rid="article-38205.r1">[1]</xref></p>
      </sec>
      <sec id="article-38205.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The infections caused by <italic toggle="yes">E. coli</italic> O157:H7 range from asymptomatic to severe. Few individuals can develop potentially fatal complications like hemolytic uremic syndrome (HUS). Chronic renal pathology may persist at times among those that survive. Humans are known to acquire <italic toggle="yes">E. coli</italic> O157:H7 in multiple ways, for example, contaminated food and water and direct contact with infected animals and humans. Consumption of contaminated food like ground beef, dairy products, and fresh produce is responsible for the majority of the outbreaks.&#x000a0;<xref ref-type="bibr" rid="article-38205.r2">[2]</xref></p>
        <p>Cattle are considered as the principal reservoirs for <italic toggle="yes">E.coli</italic> O157:H7; contamination takes place through their use as food, their manure used as a fertilizer, and through water supplies contaminated by runoff from cattle farms. Although variation has been reported in fecal shedding of <italic toggle="yes">E. coli</italic> O157:H7 has been ranging from 0 to 80% among the cattle population, a seasonal pattern has also been shown, with prevalence increasing during summer months. Elevated temperature in summers might be responsible for favoring bacterial proliferation and survival.</p>
      </sec>
      <sec id="article-38205.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The Centers for Disease Control and Prevention (CDC) estimated that foodborne <italic toggle="yes">E. coli</italic> O157:H7&#x000a0;is responsible for over 63,000 illnesses per year that leads to more than 2100 hospitalizations and deaths in the United States. The economic burden of illness due to this bacteria resulting from medical expenses and death and loss of productivity is estimated to be $405 million per year.&#x000a0;<xref ref-type="bibr" rid="article-38205.r3">[3]</xref><xref ref-type="bibr" rid="article-38205.r4">[4]</xref></p>
        <p>According to the 10 US sites of the Foodborne Diseases Active Surveillance Network (FoodNet) preliminary report of 2017, STEC was listed as one of the 9 pathogens commonly transmitted by food. As compared to the incidence 2014 through 2016 the incidence in 2017 was 28% higher. Fifty-seven cases of HUS were identified in 2016; the incidence was not significantly different from 2013 through 2015.</p>
        <p>In Norway, HUS was labeled as the second most common cause of acute kidney&#x000a0;infection (AKI) in children with an estimated average annual incidence of 0.5 cases per 100,000 children.</p>
      </sec>
      <sec id="article-38205.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>On entry, EHEC strains produce Shiga-like toxins (Stx) which mediate the dysregulation of membrane ion channels in the epithelial membrane of the intestine that leads to loss of ions and a massive amount of water. This toxin also acts as a cell transduction and immune modulator leading to pro-inflammatory and pro-apoptotic sequela. Endothelial lesions in the microvasculature of the kidney and less frequently of other organs are found to be responsible for sequela of the hemolytic uremic syndrome. The kidney and gastrointestinal (GI) tract are the most commonly affected organs in HUS, but evidence of central nervous system (CNS), pancreatic, skeletal, and myocardial involvement has also been shown in the studies conducted. The mechanism of this microvascular injury is unknown, but evidence shows that verocytotoxin plays a role in mediating cell injury with a resultant change in the normal anti-coagulant profile of the endothelial cell to a procoagulant state.&#x000a0;<xref ref-type="bibr" rid="article-38205.r5">[5]</xref>&#x000a0;</p>
        <p>After<italic toggle="yes"> E. coli</italic> infection, several factors determine the progression of the disease to HUS like:</p>
        <list list-type="order">
          <list-item>
            <p><italic toggle="yes">Bacterial strain:</italic> Serotype O157:H7 is most often found to be responsible</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Age:</italic> The rate of progression to HUS is higher in young children. A study showed it to be 12.9% in children younger than 5 years of age, 6.8% in children between 5 to 10 years, 8% in children older than&#x000a0;10 years of age.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Antibiotic:</italic> Treatment with antibiotic therapy for <italic toggle="yes">E. coli</italic> O157:H7 has shown to increase the risk of HUS</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Environmental and genetic factors</italic>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-38205.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>In the acute phase of HUS, specimens of the kidney show microvascular injury characterized by deposition of microthrombi along with detached and swollen glomerular endothelial cells associated with infiltration of inflammatory cells. Similar changes have been described in other organs. This shows that HUS is a multisystem disease characterized by endothelial cell injury.&#x000a0;<xref ref-type="bibr" rid="article-38205.r6">[6]</xref></p>
      </sec>
      <sec id="article-38205.s7" sec-type="Toxicokinetics">
        <title>Toxicokinetics</title>
        <p>Enterohemorrhagic <italic toggle="yes">E. coli</italic> is not invasive, making bacteremia rare. It adheres to mammalian cells, secreting bacterial proteins into host cells through a type III secretion system. Ribosome-inactivating Shiga-like toxins (Stx1 and Stx2) are secreted which are responsible for organ damage. Stx 2 has been found to be more often associated with severe disease. Shiga toxin consists of 2 subunits: A and B. Proteolysis further degrades subunit A into A1 and A2. In target organs, for example, the kidney, brain,&#x000a0;and gut, subunit B attaches to glycolipid receptors on the cell surface. In humans, these receptors have been identified as Gb3 which are mainly expressed in kidney tubular cells, brain, and gut epithelium. The cytotoxicity is further amplified in the kidney due to the interplay of tumor necrosis factor-alpha. After it binds to the cell surface, Shiga toxin is endocytosed and transported to the Golgi apparatus and endoplasmic reticulum in a retrograde direction from there it is then translocated to the cytosol where it inactivates ribosomes and causes cell death.&#x000a0;<xref ref-type="bibr" rid="article-38205.r5">[5]</xref><xref ref-type="bibr" rid="article-38205.r7">[7]</xref></p>
      </sec>
      <sec id="article-38205.s8" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>EHEC clinically manifests as bloody diarrhea (visibly bloody stool specimen) without fever and usually a white blood cell count above 10,000/microL at times associated with abdominal pain. The incubation period between exposure to EHEC and onset of symptoms is typically 3 to 4 days.&#x000a0;<xref ref-type="bibr" rid="article-38205.r8">[8]</xref><xref ref-type="bibr" rid="article-38205.r3">[3]</xref><xref ref-type="bibr" rid="article-38205.r7">[7]</xref></p>
        <p>HUS is a major complication of EHEC infection. It is a clinical triad of anemia secondary to hemolysis, impaired renal function, and thrombocytopenia&#x000a0;mainly affecting young children. HUS following bloody diarrhea secondary to EHEC is called D+ HUS or typical HUS; whereas, HUS caused by other causes is referred to as D- HUS or atypical HUS.</p>
      </sec>
      <sec id="article-38205.s9" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Patients suspected of infection from EHEC are tested for Shiga toxin or EHEC by doing stool culture. Blood tests and urine tests are also conducted&#x000a0;in patients presenting with HUS which can show low red blood cell and platelet count and&#x000a0;assess renal functions respectively.&#x000a0;<xref ref-type="bibr" rid="article-38205.r9">[9]</xref></p>
      </sec>
      <sec id="article-38205.s10" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Supportive treatment is provided to those having EHEC diarrhea.<xref ref-type="bibr" rid="article-38205.r5">[5]</xref></p>
        <p>Electrolytes and water deficiency should be replaced, especially in patients with D+ HUS. The current advancements in dialysis and intensive care have reduced mortality, mainly in young children. The best option for children is peritoneal dialysis. Bilateral nephrectomy is life-saving and can control the spread of microvascular lesions when the kidneys are the main site of the disease involvement especially in cases of therapy-resistant malignant hypertension.<xref ref-type="bibr" rid="article-38205.r5">[5]</xref> Because the prognosis is often severe, immediate supportive treatment may improve the outcome. Other supportive treatments available&#x000a0;for patients with HUS are mainly dependent on their symptoms and mainly include:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Red blood cell transfusions</p>
          </list-item>
          <list-item>
            <p>Platelet transfusions</p>
          </list-item>
          <list-item>
            <p>Plasma exchange</p>
          </list-item>
        </list>
        <p>In general, the prevention of foodborne diseases must be based on good hygienic practices and control of the contamination of foods by biological and chemical hazards. This can be achieved most effectively through the application of food safety assurance programs. Vaccines for EHEC are under study but have not been approved by FDA yet.</p>
      </sec>
      <sec id="article-38205.s11" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>In all patients with HUS symptoms, Shiga toxin/STEC should be tested along with ADAMTS13 activity as clinical presentation, and the organ involvement in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura can overlap. In patients of unusual age or in whom diarrhea is absent anomalous or atypical&#x000a0;<italic toggle="yes">E. coli,</italic>&#x000a0;HUS is a possible diagnosis.&#x000a0;<xref ref-type="bibr" rid="article-38205.r5">[5]</xref></p>
      </sec>
      <sec id="article-38205.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Diagnosing EHEC infection early and starting prompt fluid replacement has shown to improve long-term outcomes by reducing damage to the kidney. Advancement in dialysis therapy and improved care of critically ill children have resulted in a significant reduction in acute mortality of HUS to such an extent that chronic complications in long-term survivors are becoming more apparent.&#x000a0;<xref ref-type="bibr" rid="article-38205.r10">[10]</xref></p>
      </sec>
      <sec id="article-38205.s13" sec-type="Complications">
        <title>Complications</title>
        <p>Often, EHEC associated with bloody diarrhea can resolve without any long-term consequences. The prognosis is severe mainly in patients developing HUS. After being treated for HUS, some children can never recover renal functions and thus require long-term replacement therapies for renal functions whereas those who recover renal functions are at risk of late development of renal disease. Some children may have residual extrarenal problems including neurological defects, insulin-dependent diabetes mellitus, pancreatic insufficiency, or gastrointestinal complications. HUS is thus a disease with substantial mortality and multisystem morbidity.&#x000a0;This shows that importance should be given to extra-renal manifestations in the acute phase and renal functions should be monitored in long-term follow-up of HUS patients.&#x000a0;<xref ref-type="bibr" rid="article-38205.r11">[11]</xref></p>
      </sec>
      <sec id="article-38205.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Taking measures like usage of drinkable water for food preparation, observing improved hygienic conditions during the slaughter of animals, use of appropriate measures of food processing, cooking food properly, educating/teaching food handlers and farm workers about the principles of food hygiene, and its application can significantly reduce the incidence of EHEC infections.</p>
      </sec>
      <sec id="article-38205.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>EHEC is a foodborne disease that can be reduced by practicing good hygiene and controlling the contamination of food. It is a human pathogen found to be responsible for bloody diarrhea outbreaks and hemolytic uremic syndrome (HUS) worldwide. There is no specific treatment, but studies are being conducted. Supportive measurements are the mainstay of treatment.</p>
      </sec>
      <sec id="article-38205.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of EHEC is interprofessional. For most patients,&#x000a0;supportive treatment will suffice. Electrolytes and water deficiency should be replaced, especially in patients with D+ HUS. The current advancements in dialysis and intensive care have reduced mortality, mainly in young children. The best option for children is peritoneal dialysis. Bilateral nephrectomy is life-saving and can control the spread of microvascular lesions when the kidneys are the main site of the disease involvement especially in cases of therapy-resistant malignant hypertension. Because the prognosis is often severe, immediate supportive treatment may improve the outcome. Other supportive treatments available&#x000a0;for patients with HUS are mainly dependent on their symptoms and may include plasma exchange and blood transfusions.</p>
        <p>In general, the primary care provider and nurse practitioner should educate the patient on the prevention of foodborne diseases.&#x000a0; This can be achieved most effectively through the application of food safety assurance programs. Vaccines for EHEC are under study but have not been approved by FDA yet.<xref ref-type="bibr" rid="article-38205.r12">[12]</xref></p>
      </sec>
      <sec id="article-38205.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=38205&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=38205">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/enterohemorrhagic-escherichia-coli/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=38205">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/38205/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=38205">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-38205.s18">
        <title>References</title>
        <ref id="article-38205.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ameer</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wasey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salen</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Escherichia coli (e Coli 0157 H7)</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">29939622</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38205.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beauvais</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Gart</surname>
                <given-names>EV</given-names>
              </name>
              <name>
                <surname>Bean</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Blanco</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wilsey</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McWhinney</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bryan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Krath</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Manriquez Alvarez</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Paudyal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bryan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Lahodny</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Baumgarten</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gautam</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nightingale</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lawhon</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Pinedo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ivanek</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The prevalence of Escherichia coli O157:H7 fecal shedding in feedlot pens is affected by the water-to-cattle ratio: A randomized controlled trial.</article-title>
            <source>PLoS One</source>
            <year>2018</year>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>e0192149</fpage>
            <pub-id pub-id-type="pmid">29414986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38205.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jenssen</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Vold</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hovland</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bangstad</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Nyg&#x000e5;rd</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bjerre</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.</article-title>
            <source>BMC Infect Dis</source>
            <year>2016</year>
            <month>Jun</month>
            <day>13</day>
            <volume>16</volume>
            <fpage>285</fpage>
            <pub-id pub-id-type="pmid">27297224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38205.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marder Mph</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Cieslak</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hurd</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jervis</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lathrop</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Muse</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tobin-D'Angelo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vugia</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Holt</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Wolpert</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Tauxe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Geissler</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Preliminary Incidence and Trends of Infections with Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2006-2017.</article-title>
            <source>MMWR Morb Mortal Wkly Rep</source>
            <year>2018</year>
            <month>Mar</month>
            <day>23</day>
            <volume>67</volume>
            <issue>11</issue>
            <fpage>324</fpage>
            <page-range>324-328</page-range>
            <pub-id pub-id-type="pmid">29565841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38205.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salvadori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bertoni</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.</article-title>
            <source>World J Nephrol</source>
            <year>2013</year>
            <month>Aug</month>
            <day>06</day>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>56</fpage>
            <page-range>56-76</page-range>
            <pub-id pub-id-type="pmid">24255888</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38205.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bystrom</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Beck</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Prahlow</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Hemolytic uremic syndrome caused by E. coli O157 infection.</article-title>
            <source>Forensic Sci Med Pathol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>240</fpage>
            <page-range>240-244</page-range>
            <pub-id pub-id-type="pmid">28352987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38205.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mayer</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Leibowitz</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Kurosawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stearns-Kurosawa</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.</article-title>
            <source>Toxins (Basel)</source>
            <year>2012</year>
            <month>Nov</month>
            <day>08</day>
            <volume>4</volume>
            <issue>11</issue>
            <fpage>1261</fpage>
            <page-range>1261-87</page-range>
            <pub-id pub-id-type="pmid">23202315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38205.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gomes</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Elias</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Scaletsky</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Guth</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Piazza</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Martinez</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>Diarrheagenic Escherichia coli.</article-title>
            <source>Braz J Microbiol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>47 Suppl 1</volume>
            <issue>Suppl 1</issue>
            <fpage>3</fpage>
            <page-range>3-30</page-range>
            <pub-id pub-id-type="pmid">27866935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38205.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheong</surname>
                <given-names>HI</given-names>
              </name>
              <name>
                <surname>Jo</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YO</given-names>
              </name>
              <name>
                <surname>Koo</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea.</article-title>
            <source>J Korean Med Sci</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>31</volume>
            <issue>10</issue>
            <fpage>1516</fpage>
            <page-range>1516-28</page-range>
            <pub-id pub-id-type="pmid">27550478</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38205.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grisaru</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Management of hemolytic-uremic syndrome in children.</article-title>
            <source>Int J Nephrol Renovasc Dis</source>
            <year>2014</year>
            <volume>7</volume>
            <fpage>231</fpage>
            <page-range>231-9</page-range>
            <pub-id pub-id-type="pmid">24966691</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38205.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rahal</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Kazzi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nassar</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Matar</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.</article-title>
            <source>Front Cell Infect Microbiol</source>
            <year>2012</year>
            <volume>2</volume>
            <fpage>138</fpage>
            <pub-id pub-id-type="pmid">23162800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-38205.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saeedi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yazdanparast</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Behzadi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Salmanian</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Mousavi</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Nazarian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Amani</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A review on strategies for decreasing E.&#x000a0;coli O157:H7 risk in animals.</article-title>
            <source>Microb Pathog</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>103</volume>
            <fpage>186</fpage>
            <page-range>186-195</page-range>
            <pub-id pub-id-type="pmid">28062285</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
